Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Unimolecular polypharmacy for treatment of diabetes and obesity
North America contributes the largest share to the market as the region has a structured ecosystem for adopting GLP-1 analogs
High MOQs can create inventory risk
In 2024, tirzepatide also gained authorization for managing moderate-to-severe obstructive sleep apnea (OSA) in obese adults (Malhotra et al., 2024)
It does not write data back to Apple Health
US$ 22.46
US$ 27.05
US$ 20.88
US$ 26.86
US$ 22.69
US$ 29.16
US$ 28.71
US$ 20.27
US$ 25.35
US$ 26.60
US$ 23.90
US$ 29.24
US$ 21.00
US$ 25.23
US$ 29.44
